Updated Oct 28, 2026 · 12:56 UTC
NBIXNeurocrine Biosciences, Inc.
Health Care · United States · XNAS · biological products, (no diagnostic substances)
$145.22+0.09%last session · market early-hours
Market cap
$14.76b
real-world
Tokenized
$34
<0.001% of the asset
Avg token price
$135.72
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
NBIX · Price
EarningsNasdaq’s earnings calendar
Next earnings
Nov 2
after the close · Sep 2026 quarter · EPS forecast $1.99 (7 analysts)
Last earnings, Jul 30
$2.36 EPS
+25.5% vs $1.88 forecast · Jun 2026 quarter
Real marketNeurocrine Biosciences Inc
Last close
$146.00
Oct 27
Traded on Oct 27
$171.7m
Price now
$145.22
market early-hours
Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet
In DeFiPools and lending markets that hold these tokens
None found
Onchain versions1 token from 1 issuer
wNBIXxBacked Assets——Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$3.37b
+34% YoY
Operating income
$794.8m
24% margin · +61% YoY
Net income
$705.5m
21% margin · +103% YoY
EPS, diluted
$6.77
+96% YoY
Diluted shares
104m
+3% YoY
Cash and balance sheet
Free cash flow
$870.4m
26% of revenue · 5.9% yield
Cash and securities
$481.7m
debt not tagged
Quarterly
RevenueNet income
Valuation today’s market cap $14.76b
P/E
20.9×
P/S
4.4×